Diana Brainard - 18 Nov 2022 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Executive Officer, Director
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
18 Nov 2022
Net transactions value
-$32,810
Form type
4
Filing time
21 Nov 2022, 16:47:52 UTC
Previous filing
20 Sep 2022
Next filing
23 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $32,810 -4,515 -0.71% $7.27 633,033 18 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.23 to $7.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.